Ligand Pharmaceuticals
LGND
293.26
-3.68
-1.24%
Ligand Pharmaceuticals
US · LGND
#1920 by market cap
Listed 1970
293.26
-3.68
-1.24%
Live - 5344 symbols - heartbeat 445s ago
· 2026-10-08 04:39
Pre-market
291.51
-0.60%
After-hours
293.26
0.00%
- Market cap
- 5.85B
- P/E (TTM)i
- 30.20
- P/Bi
- 6.04
- EPSi
- 6.13
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on LGND?
Anonymous reader poll. Unscientific, not investment advice.
About Ligand Pharmaceuticals
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
- Founded
- 1987
- CEO
- Mr. Todd C. Davis
- Employees
- 47
- Headquarters
- Jupiter, Florida, United States of America
- Fiscal year end
- 12-31
- Website
- ligand.com
Company profile
- Exchange
- US
- Symbol
- LGND
- Market-cap rank
- #1920
- Listing date
- 1970-01-01
- Market cap
- 5.85B
- Float cap
- 5.71B
- Shares out
- 19.94M
- Float shares
- 19.48M
Sectors & themes
Quote time 2026-10-08 04:39:31 · For reference only, not investment advice and not tailored to your situation.